Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP537237.RAVVACyEk4lJA9BNNkVBeFVolKswfGZ6RXy_UdGYg6Fo8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP537237.RAVVACyEk4lJA9BNNkVBeFVolKswfGZ6RXy_UdGYg6Fo8130_assertion type Assertion NP537237.RAVVACyEk4lJA9BNNkVBeFVolKswfGZ6RXy_UdGYg6Fo8130_head.
- NP537237.RAVVACyEk4lJA9BNNkVBeFVolKswfGZ6RXy_UdGYg6Fo8130_assertion description "[Because solid tumors expressing ECGF-1 could also be lysed by the CTL, ECGF-1 is an interesting target for immunotherapy of both hematologic and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP537237.RAVVACyEk4lJA9BNNkVBeFVolKswfGZ6RXy_UdGYg6Fo8130_provenance.
- NP537237.RAVVACyEk4lJA9BNNkVBeFVolKswfGZ6RXy_UdGYg6Fo8130_assertion evidence source_evidence_literature NP537237.RAVVACyEk4lJA9BNNkVBeFVolKswfGZ6RXy_UdGYg6Fo8130_provenance.
- NP537237.RAVVACyEk4lJA9BNNkVBeFVolKswfGZ6RXy_UdGYg6Fo8130_assertion SIO_000772 16497972 NP537237.RAVVACyEk4lJA9BNNkVBeFVolKswfGZ6RXy_UdGYg6Fo8130_provenance.
- NP537237.RAVVACyEk4lJA9BNNkVBeFVolKswfGZ6RXy_UdGYg6Fo8130_assertion wasDerivedFrom befree-2016 NP537237.RAVVACyEk4lJA9BNNkVBeFVolKswfGZ6RXy_UdGYg6Fo8130_provenance.
- NP537237.RAVVACyEk4lJA9BNNkVBeFVolKswfGZ6RXy_UdGYg6Fo8130_assertion wasGeneratedBy ECO_0000203 NP537237.RAVVACyEk4lJA9BNNkVBeFVolKswfGZ6RXy_UdGYg6Fo8130_provenance.